Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Epilepsia ; 59(11): 2137-2144, 2018 11.
Artículo en Inglés | MEDLINE | ID: mdl-30338512

RESUMEN

OBJECTIVE: The majority of the 65 million people worldwide with epilepsy live in low- and middle-income countries. Many of these countries have inadequate resources to serve the large patient population affected by epilepsy. Panama is a middle-income country that currently has only 2 facilities that can provide basic epilepsy services and no epilepsy surgery services. To address this need, a group of Panamanian physicians partnered with U.S. epilepsy health care providers to test a hybrid epilepsy surgery program, combining resources and expertise. METHODS: From 2011 to 2017, a multidisciplinary team of neurologists, neurosurgeons, and an electroencephalography (EEG) technician from the United States traveled to Panama 6 times and, in collaboration with the local team, performed surgical procedures for intractable epilepsy at the national children's hospital. Resective surgeries were performed with intraoperative electrocorticography and/or implantation of subdural and depth electrodes and extra-operative monitoring. Cost was calculated using Panama government data. RESULTS: Twenty-seven children with intractable epilepsy were surgically treated. Fifteen children are seizure-free (Engle class I), 11 children are Engel II, and one child is Engel III. No major morbidity or mortality occurred, with only one postoperative infection. The average cost of treatment was calculated at $9850 per patient. SIGNIFICANCE: This program is a model for creating a multinational and multi-institutional collaboration to provide surgical epilepsy treatment in a middle-income country without an adequate infrastructure. To be successful, this collaboration needed to address medical, technical, and cultural challenges. This partnership helps to alleviate some of the present need for surgical epilepsy services while laying the groundwork for the development of a future local independent epilepsy surgery program.


Asunto(s)
Epilepsia/epidemiología , Epilepsia/cirugía , Procedimientos Neuroquirúrgicos/métodos , Evaluación de Programas y Proyectos de Salud/métodos , Adolescente , Niño , Preescolar , Electroencefalografía , Epilepsia/economía , Femenino , Estudios de Seguimiento , Hospitales/estadística & datos numéricos , Hospitales/provisión & distribución , Humanos , Cooperación Internacional , Masculino , Procedimientos Neuroquirúrgicos/economía , Panamá/epidemiología , Evaluación de Programas y Proyectos de Salud/economía , Estudios Retrospectivos , Resultado del Tratamiento
2.
J Org Chem ; 79(20): 9647-54, 2014 Oct 17.
Artículo en Inglés | MEDLINE | ID: mdl-25238507

RESUMEN

On the basis of previous conformational and configurational studies of 4-aryl-substituted cyclophosph(on)ates derived from d-xylofuranose derivatives, wherein it was proposed that the anomeric effect is involved in the spontaneous isomerization of the P atom and the C4 carbon, and consequently, this unusual behavior was associated with the cleavage of the HepDirect prodrugs. We synthesized an analogous series of 2-amino-2-oxo-1,3,2-dioxaphosphorinanes and performed a conformational and configurational analysis in solution and the solid state followed by an examination of their mutagenic activity. The results showed that the 2-amino-2-oxo-1,3,2-dioxaphosphorinanes with the largest mutagenic activity contain either a 4-methoxyphenyl or 4-fluorophenyl group at C4 carbon and presented a major chair conformation, which is prone to weaken the C4-O3 bond via the anomeric effect and facilitates the cleavage for the release of the biologically active metabolite.


Asunto(s)
Ciclofosfamida/química , Compuestos Organofosforados/química , Profármacos/química , Isomerismo , Modelos Moleculares , Conformación Molecular
3.
N Engl J Med ; 369(8): 732-44, 2013 Aug 22.
Artículo en Inglés | MEDLINE | ID: mdl-23964935

RESUMEN

BACKGROUND: The eastern equine encephalitis (EEE) and Venezuelan equine encephalitis (VEE) viruses are pathogens that infect humans and horses in the Americas. Outbreaks of neurologic disease in humans and horses were reported in Panama from May through early August 2010. METHODS: We performed antibody assays and tests to detect viral RNA and isolate the viruses in serum samples from hospitalized patients. Additional cases were identified with enhanced surveillance. RESULTS: A total of 19 patients were hospitalized for encephalitis. Among them, 7 had confirmed EEE, 3 had VEE, and 1 was infected with both viruses; 3 patients died, 1 of whom had confirmed VEE. The clinical findings for patients with EEE included brain lesions, seizures that evolved to status epilepticus, and neurologic sequelae. An additional 99 suspected or probable cases of alphavirus infection were detected during active surveillance. In total, 13 cases were confirmed as EEE, along with 11 cases of VEE and 1 case of dual infection. A total of 50 cases in horses were confirmed as EEE and 8 as VEE; mixed etiologic factors were associated with 11 cases in horses. Phylogenetic analyses of isolates from 2 cases of equine infection with the EEE virus and 1 case of human infection with the VEE virus indicated that the viruses were of enzootic lineages previously identified in Panama rather than new introductions. CONCLUSIONS: Cases of EEE in humans in Latin America may be the result of ecologic changes that increased human contact with enzootic transmission cycles, genetic changes in EEE viral strains that resulted in increased human virulence, or an altered host range. (Funded by the National Institutes of Health and the Secretaría Nacional de Ciencia, Tecnología e Innovación, Panama.).


Asunto(s)
Brotes de Enfermedades , Virus de la Encefalitis Equina del Este , Virus de la Encefalitis Equina Venezolana , Encefalomielitis Equina Oriental , Encefalomielitis Equina Venezolana , Adolescente , Animales , Anticuerpos Antivirales/sangre , Niño , Preescolar , Virus de la Encefalitis Equina del Este/genética , Virus de la Encefalitis Equina del Este/inmunología , Virus de la Encefalitis Equina del Este/aislamiento & purificación , Virus de la Encefalitis Equina Venezolana/genética , Virus de la Encefalitis Equina Venezolana/inmunología , Virus de la Encefalitis Equina Venezolana/aislamiento & purificación , Encefalomielitis Equina Oriental/epidemiología , Encefalomielitis Equina Oriental/veterinaria , Encefalomielitis Equina Venezolana/epidemiología , Encefalomielitis Equina Venezolana/veterinaria , Resultado Fatal , Femenino , Enfermedades de los Caballos/epidemiología , Caballos , Humanos , Lactante , Masculino , Panamá/epidemiología , Filogenia , ARN Viral/sangre
4.
Mol Cell Biochem ; 313(1-2): 53-61, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18373278

RESUMEN

Silymarin is a naturally available bioflavonoid and is a strong antioxidant with a capacity to inhibit the formation of tumors in several cancer models. In the present study, we investigated whether dietary supplementation of silymarin has any role in lipid components, lipid-metabolizing enzymes, free fatty acid profile, and expression of cyclooxygenase-2 (COX-2) in N-nitrosodiethylamine (NDEA)-induced hepatocellular carcinoma in rats. NDEA-induced rats showed severe hyperlipidemia along with upregulated expression of COX-2 as revealed by western blotting and immunohistochemistry. Dietary silymarin supplementation attenuated this hyperlipidemia and downregulated the expression of COX-2. Thus we conclude that compounds like silymarin with potent hypolipidemic effect are strong candidates as chemopreventive agents for the treatment of liver cancer.


Asunto(s)
Carcinoma Hepatocelular/complicaciones , Ciclooxigenasa 2/metabolismo , Regulación hacia Abajo/efectos de los fármacos , Hiperlipidemias/complicaciones , Hiperlipidemias/enzimología , Neoplasias Hepáticas/complicaciones , Silimarina/farmacología , Animales , Ácido Araquidónico/metabolismo , Carcinoma Hepatocelular/tratamiento farmacológico , Carcinoma Hepatocelular/enzimología , HDL-Colesterol/sangre , Dietilnitrosamina , Hidroximetilglutaril-CoA Reductasas/metabolismo , Hiperlipidemias/tratamiento farmacológico , Immunoblotting , Metabolismo de los Lípidos/efectos de los fármacos , Hígado/efectos de los fármacos , Hígado/enzimología , Hígado/patología , Neoplasias Hepáticas/tratamiento farmacológico , Neoplasias Hepáticas/enzimología , Masculino , Fitoterapia , Ratas , Ratas Wistar , Silimarina/uso terapéutico
5.
Pediatr Infect Dis J ; 23(2): 114-8, 2004 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-14872175

RESUMEN

BACKGROUND: The pathogenesis of HIV encephalopathy is poorly understood especially in children. Studies suggest that HIV replication and the release of proinflammatory mediators in the central nervous system contribute to the pathogenesis of HIV dementia in adults. METHODS: Cerebrospinal fluid (CSF) and plasma samples from 23 HIV-infected children were longitudinally analyzed at Weeks 0, 8, 16 and 48 for HIV RNA and concentrations of the following proinflammatory mediators: monocyte chemotactic protein-1 (MCP-1), tumor necrosis factor-alpha, regulated upon activation, normal T cell expressed and secreted (RANTES), macrophage-inflammatory protein (MIP)-1-alpha, MIP-1-beta and matrix metalloproteinase-9 (MMP-9). RESULTS: All 23 children had detectable concentrations of MCP-1 in the CSF at all time points evaluated. However, of the remaining of proinflammatory mediators measured in CSF at baseline, only a few children had detectable concentrations: tumor necrosis factor-alpha, n = 1; RANTES, n = 5; MMP-9, n = 9; MIP-1-alpha and MIP-1-beta, n = 0. A reduction from baseline to Week 48 was observed in CSF concentrations of MCP-1 and, among children with detectable values, MMP-9, which paralleled declines in CSF HIV RNA. CONCLUSION: These results suggest that MCP-1 and MMP-9 may be involved in the pathogenesis of central nervous system disease in HIV-infected children.


Asunto(s)
Complejo SIDA Demencia/diagnóstico , Fármacos Anti-VIH/administración & dosificación , Mediadores de Inflamación/sangre , Mediadores de Inflamación/líquido cefalorraquídeo , Carga Viral , Complejo SIDA Demencia/sangre , Complejo SIDA Demencia/líquido cefalorraquídeo , Complejo SIDA Demencia/tratamiento farmacológico , Quimiocina CCL2/sangre , Quimiocina CCL2/líquido cefalorraquídeo , Quimiocina CCL5/líquido cefalorraquídeo , Niño , Preescolar , Método Doble Ciego , Femenino , Humanos , Lactante , Masculino , Metaloproteinasa 9 de la Matriz/análisis , Metaloproteinasa 9 de la Matriz/sangre , Metaloproteinasa 9 de la Matriz/líquido cefalorraquídeo , Probabilidad , Pronóstico , ARN Viral/análisis , Valores de Referencia , Sensibilidad y Especificidad , Estadísticas no Paramétricas , Factor de Necrosis Tumoral alfa/análisis , Replicación Viral/efectos de los fármacos
6.
Gac Med Mex ; 139(5): 493-9, 2003.
Artículo en Español | MEDLINE | ID: mdl-14635568

RESUMEN

Caspases are key proteins for the transduction and ejection of the apoptotic signals induced by several stimuli. These proteins are present within the cell as inactive precursors that need a proteolytic cleavage in order to be active. There are two main caspases group, the initiators and executors. The formers are activated by autoproteolysis when translocated to specific cell compartments or trough the coupling of adapters and or activators. The executors caspases are activated by cleavage of an initiator caspase. These proteases are responsible then for the final cleavage of diverse substrates that mediate the morphologic changes during apoptosis. Among these there are signalization, DNA repairing, structure, transcription proteins, etc. Caspases represent a new paradigm in the signal transduction pathway, and are implicated in a large number of physiologic and pathologic processes. In a near future they could be useful pathologic markers and therapeutic targets.


Asunto(s)
Apoptosis/fisiología , Caspasas/fisiología , Animales , Inhibidores de Caspasas , Humanos
7.
J Pediatr ; 141(1): 36-44, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12091849

RESUMEN

OBJECTIVES: This study evaluated the effect of treatment with abacavir/lamivudine/zidovudine versus lamivudine/zidovudine on cerebrospinal fluid (CSF) human immunodeficiency virus (HIV) RNA and clinical manifestations of HIV encephalopathy in children. STUDY DESIGN: HIV-infected children 7 months to 10 years of age (n = 23) were studied. CSF and plasma were obtained at baseline and weeks 8, 16, and 48. Genotype analysis of HIV was attempted at baseline and week 48. Neurologic evaluations were performed at baseline and weeks 16, 32, and 48. RESULTS: At baseline, 83% of children had >2.00 log(10) copies/mL HIV RNA in CSF, but only 10% had HIV RNA measurable at week 48. Among children in whom paired genotyping of HIV was possible, 8 of 11 had identical patterns in both CSF and plasma at baseline, whereas at week 48, only 1 of 9 children had similar patterns. Neurologic abnormalities were observed in 83% of children at baseline but only 35% of children at week 48 (P =.004), suggesting a benefit of treatment. CONCLUSIONS: Antiretroviral therapy was associated with a decline in CSF HIV RNA and an improvement in neurologic status. The development of genotypic mutations was different in CSF and plasma, suggesting discordant viral evolution. These results suggest that antiretroviral treatment in children should include agents with activity in the CNS.


Asunto(s)
Complejo SIDA Demencia/tratamiento farmacológico , Fármacos Anti-VIH/uso terapéutico , Didesoxinucleósidos/uso terapéutico , VIH-1 , Lamivudine/uso terapéutico , Zidovudina/uso terapéutico , Complejo SIDA Demencia/clasificación , Complejo SIDA Demencia/diagnóstico , Fármacos Anti-VIH/farmacología , Niño , Preescolar , Didesoxinucleósidos/farmacología , Farmacorresistencia Viral , Quimioterapia Combinada , VIH-1/efectos de los fármacos , VIH-1/genética , Humanos , Lactante , Lamivudine/farmacología , ARN Viral/sangre , ARN Viral/líquido cefalorraquídeo , Estadísticas no Paramétricas , Carga Viral , Zidovudina/farmacología
8.
Sucre; 2000. 88 p. ilus.
Tesis en Español | LIBOCS, LIBOSP | ID: biblio-1315642

RESUMEN

La situación del área de salud del Instituto Politécnico Tomás Katari (IPTK) se determina mediante un diagnóstico que respalda el problema planteado. Para esta tarea se utiliza los métodos directos como la entrevista a pacientes, métodos informales, datos estadísticos, prevalencias de patologías atendidas en el policlínico del IPTK determinando de esta forma las condicionantes en las que se desarrolla nuestro objeto de estudio, que se constituye en un grupo de pacientes, que tienen un problema común, el incumplimiento de tratamiento prescrito por el médico

9.
Rev. méd. domin ; 53(1): 14-8, ene.-mar. 1992. ilus
Artículo en Español | LILACS | ID: lil-132022

RESUMEN

De agosto a septiembre de 1991, se realizó una encuesta epidemiológica transversal dirigida a 260 odontólogos de Santo Domingo, República Dominicana, para obtener sus opiniones sobre el SIDA y la discriminación de que son objeto los pacientes. Se obtuvo respuesta de 215 adontólogos, es decir, 82.7 por ciento. Los resultados de la encuesta señalan que 82.4 por ciento de los odontólogos interroga a sus pacientes sobre el SIDA, no encontrándose significación estadistica (p-NS) al compararlos según edad, sexo y especialidad. La mayoria (88.4 por ciento ) no solicita a sus pacientes la prueba del HIV. La encuesta reveló que solo 4.7 por ciento de los odontólogos ha atendido a pacientes seropositivos y/o con SIDA, y 64.7 por ciento los discrimina. Los homosexuales (70.2 por ciento ), las trabajadoras del sexo (55.0 por ciento ), los toxicómanos (52.1 por ciento ) y los hemofílicos (40.5 por ciento ) son los grupos de riesgo más discriminados, justificando esta actitud por temor a: "perder sus clientes" (78.1 por ciento ), a "contagiarse" (47.9 por ciento ), "contaminar sus instrumentos" (38.1 por ciento ) y "afectación de su imagen social" (20.5 por ciento ). Sin embargo, admiten que el codigo deontológico los obliga a brindar sus servicios, aunque 24.7 por ciento no reconoce esta obligación moral. Por último, según estos resultados, debe admitirse un claro reconocimiento de que el riesgo existe y que la preocupación entre los profesionales de la salud es justificada


Asunto(s)
Humanos , Masculino , Femenino , Adulto , Persona de Mediana Edad , Encuestas Epidemiológicas , Odontólogos , Síndrome de Inmunodeficiencia Adquirida/psicología , Discriminación en Psicología
10.
Sucre; s.n; 00001989. 60 p. tab, graf.
Tesis en Español | LILACS-Express | LIBOCS, LIBOSP | ID: biblio-1335472

RESUMEN

Las enfermedades han afectado siempre a la humanidadpero el esfuerzo en la investigacion y el conocimiento adquirido en estos trabajos, permitio descubrir medicamentos que a lo largo de nuestra historia han servido para curar diferentes males. En la lista de medicamentos indespensables indicados por la O.M.S.para el uso de los paisesdel tercer mundo, se encuentra la vitamina C. cuyos efectos beneficiosos son ampliamente conocidos. Siendo esta vitamina de gran consumo en nuestra sociedad, las industrias farmaceuticas deben tener los mecanismos de control que garanticen la optima calidad de estos, ya que se trata no solamente de la economia de las personas, sino de la salud de las mismas. La industria farmaceutica nacional, elabora vitamina C en diferentes formas farmaceuticas Tabletas, comprimidos, granulados, gotas, ampollas, utilizando normas internacionales. Existen en circulacion ampollas de vitamina C, provenientes del contrabando, que por sus precios competitivos son preferidos por la poblacion de escasos recursos economicos. No existiendo un control rigoroso de los productos que entran por esa via, de los productos de donacion...

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...